Back to Opaleye Management Inc.

Opaleye Management Inc.

All holdings · as of Dec 31, 2025

54 positions

CompanyClassValueShares% of portfolio
Harrow, Inc.$191.34M3,905,00025.2%
Liquidia CorpLQDACommon Stock$84.98M2,435,00011.2%
Eton Pharmaceuticals, Inc.$48.36M2,860,0006.4%
RHYTHM PHARMACEUTICALS, INC.$35.32M330,0004.7%
Apogee Therapeutics, Inc.$29.31M388,2573.9%
SANUWAVE Health Inc$29.28M981,2673.9%
Stoke Therapeutics, Inc.$22.06M695,0002.9%
Ocular Therapeutix, Inc$19.36M1,595,0002.6%
Sol-Gel Technologies Ltd$19.12M453,7392.5%
CG Oncology, Inc.$17.02M410,0002.2%
TG Therapeutics Inc$15.95M535,0002.1%
Disc Medicine, Inc.IRONCommon Stock$15.88M200,0002.1%
Rezolute, Inc.$14.84M6,287,1562.0%
CRESCENT BIOPHARMA, INC.$13.97M1,178,3001.8%
Alkermes plc.$13.71M490,0001.8%
Alpha Cognition Inc.$13.46M2,070,7841.8%
Annexon, Inc.$13.05M2,600,0001.7%
Edgewise Therapeutics, Inc.$12.41M500,0001.6%
Codexis, Inc.$11.07M6,789,7381.5%
PROTAGONIST THERAPEUTICS INC$9.17M105,0001.2%
Gossamer Bio, Inc.$8.43M2,720,0001.1%
MBX Biosciences, Inc.MBXCommon Stock$8.20M260,0001.1%
Revolution Medicines, Inc.$7.96M100,0001.1%
XOMA Royalty Corp$7.78M292,5901.0%
Journey Medical CorpDERMCommon Stock$7.52M975,0001.0%
Karyopharm Therapeutics Inc.$6.84M930,0000.9%
JADE BIOSCIENCES, INC.$6.60M427,6080.9%
UROGEN PHARMA LTD$6.29M268,4230.8%
ALUMIS INC.ALMSCommon Stock$5.22M535,0000.7%
Perspective Therapeutics, Inc.$4.99M1,184,5000.7%
Voyager Therapeutics, Inc.$4.70M1,196,9040.6%
Relmada Therapeutics, Inc.$4.52M935,0000.6%
Tectonic Therapeutic, Inc.TECXCommon Stock$4.48M214,7470.6%
Protalix BioTherapeutics, Inc.$4.46M2,478,1760.6%
Trevi Therapeutics, Inc.$4.32M345,1000.6%
Fortress Biotech, Inc.FBIOCommon Stock$3.99M1,090,0000.5%
ROCKET PHARMACEUTICALS, INC.$3.35M955,0000.4%
MEIRAGTX HOLDINGS PLC$3.11M390,8440.4%
RIGEL PHARMACEUTICALS, INC.$3.00M70,0000.4%
ZYMEWORKS INC.$2.87M108,9290.4%
ASSERTIO HOLDINGS INC$2.58M285,0000.3%
Ventyx Biosciences, Inc.$2.27M251,9320.3%
Opus Genetics, Inc.$2.25M1,120,0000.3%
Sutro Biopharma, Inc.$2.21M190,6710.3%
Cabaletta Bio, Inc.$1.97M900,0000.3%
Zentalis Pharmaceuticals, Inc.ZNTLCommon Stock$1.89M1,400,9060.2%
GENERATION BIO CO$1.76M310,0000.2%
BridgeBio Pharma, Inc.$1.40M18,3190.2%
ENANTA PHARMACEUTICALS INC$1.18M75,0000.2%
Q32 Bio Inc.$708.4K213,3630.1%
← PrevPage 1 of 2Next →